Middle East, North Africa, Afghanistan & Pakistan vs Nauru: Immunization, HepB3
Immunization, HepB3 over time
- Middle East, North Africa, Afghanistan & Pakistan
- Nauru
How they compare
Nauru currently reports 97.0% against 84.4% in Middle East, North Africa, Afghanistan & Pakistan, a difference of 12.6%.
That makes Nauru's figure about 1.1 times Middle East, North Africa, Afghanistan & Pakistan's.
The two have swapped places 2 times across 34 shared years of data; in 1991 it was Nauru ahead.
Middle East, North Africa, Afghanistan & Pakistan ranks 24th and Nauru ranks 26th of 47 groups.
Nauru has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Middle East, North Africa, Afghanistan & Pakistan | Nauru | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 22.5% | 72.6% | 50.0% | Nauru |
| 2000s | 63.5% | 85.9% | 22.4% | Nauru |
| 2010s | 80.5% | 92.0% | 11.5% | Nauru |
| 2020s | 83.4% | 96.8% | 13.4% | Nauru |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, hepb3, Middle East, North Africa, Afghanistan & Pakistan or Nauru?
- Nauru, at 97.0% against 84.4% in Middle East, North Africa, Afghanistan & Pakistan as of 2024.
- What is the difference in immunization, hepb3 between Middle East, North Africa, Afghanistan & Pakistan and Nauru?
- 12.6%, with Nauru ahead.
- How many years of comparable data are there for Middle East, North Africa, Afghanistan & Pakistan and Nauru?
- 34 years are reported by both, from 1991 to 2024.
- How do Middle East, North Africa, Afghanistan & Pakistan and Nauru rank globally for immunization, hepb3?
- Middle East, North Africa, Afghanistan & Pakistan ranks 24th and Nauru ranks 26th of 47 groups.
- Where does this data come from?
- World Health Organization (WHO), published as Immunization, HepB3 (% of one-year-old children). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization rate, hepatitis B is the percentage of children ages 12-23 months who received hepatitis B vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized after three doses.